InsidersTradesSigma
Follow the 바이오포트 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오포트 has published 5 insider filings. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: 김성구. The full history is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
n/a
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
关于 바이오포트
Bioport是一家在XKRX市场上市的医疗保健和制药公司。它专注于生物制药产品的开发。